Fig. 1: Clonal hematopoiesis (CH) is prevalent in patients with multiple myeloma (MM).
From: Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma
A Schema summarizing healthy control and MM patient study cohorts. B Violin plots showing distribution of age between the four groups. C The frequency of CH in baseline samples from four groups. D Percentage of cases with detectable CH at baseline. E Oncoprint showing co-occurring and mutually exclusive mutations in three MM study groups. F Frequencies of specific CH gene mutations in four groups. G Odds-ratios for the associations between clinical variables and the presence of CH at baseline.
